Atwood & Palmer’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Hold |
200
| – | – | ﹤0.01% | 355 |
|
|
2025
Q1 | $14.7K | Hold |
200
| – | – | ﹤0.01% | 308 |
|
|
2024
Q4 | $13.1K | Hold |
200
| – | – | ﹤0.01% | 318 |
|
|
2024
Q3 | $15.6K | Hold |
200
| – | – | ﹤0.01% | 304 |
|
|
2024
Q2 | $15.6K | Hold |
200
| – | – | ﹤0.01% | 319 |
|
|
2024
Q1 | $13.6K | Hold |
200
| – | – | ﹤0.01% | 294 |
|
|
2023
Q4 | $13.5K | Hold |
200
| – | – | ﹤0.01% | 301 |
|
|
2023
Q3 | $13.5K | Hold |
200
| – | – | ﹤0.01% | 292 |
|
|
2023
Q2 | $14.3K | Hold |
200
| – | – | ﹤0.01% | 297 |
|
|
2023
Q1 | $13.9K | Hold |
200
| – | – | ﹤0.01% | 285 |
|
|
2022
Q4 | $13.6K | Hold |
200
| – | – | ﹤0.01% | 307 |
|
|
2022
Q3 | $11K | Hold |
200
| – | – | ﹤0.01% | 300 |
|
|
2022
Q2 | $13K | Hold |
200
| – | – | ﹤0.01% | 313 |
|
|
2022
Q1 | $13K | Hold |
200
| – | – | ﹤0.01% | 349 |
|
|
2021
Q4 | $12K | Hold |
200
| – | – | ﹤0.01% | 359 |
|
|
2021
Q3 | $12K | Hold |
200
| – | – | ﹤0.01% | 343 |
|
|
2021
Q2 | $12K | Sell |
200
-100
| -33% | -$6K | ﹤0.01% | 319 |
|
|
2021
Q1 | $15K | Hold |
300
| – | – | ﹤0.01% | 317 |
|
|
2020
Q4 | $15K | Hold |
300
| – | – | ﹤0.01% | 293 |
|
|
2020
Q3 | $16K | Buy |
+300
| New | +$16K | ﹤0.01% | 241 |
|
|
2014
Q4 | – | Sell |
-60
| Closed | -$2K | – | 383 |
|
|
2014
Q3 | $2K | Hold |
60
| – | – | ﹤0.01% | 363 |
|
|
2014
Q2 | $2K | Buy |
+60
| New | +$2K | ﹤0.01% | 313 |
|